IP Library Granted Patent US 7,385,041
Granted Patent B2
US 7,385,041 · App. 10/787,526 · Granted Jun 10, 2008

Dual functioning excipient for metal chelate contrast agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,385,041
App. No.
10/787,526
Granted
Jun 10, 2008
Kind
B2
Abstract

A novel dual functioning excipient for metal chelate contrast agents is disclosed. The present excipient, X m [X′(L′)] n , which is the calcium or zinc salt of the calcium or zinc complex of an organic ligand, enhances safety in that it is able to scavenge both free metal ions and free organic ligand.

Claims (19)

1. A composition for use in magnetic resonance, x-ray, ultrasound and radio-diagnostic imaging comprising:

a contrast agent of the formula

M(L)

where M is a metal ion and L is an organic ligand of the formula

 wherein

Y is

R 1 is hydroxypropyl and R 2 is H; and

a complex salt excipient of the formula

X m [X′(L′)] n

wherein X and X′ are calcium; L′ is

 wherein

Y is

R 1 is hydroxypropyl and R 2 is H;

m is 1 and n is 2.

2. The composition of claim 1 wherein L and L′ are each 1,4,7-tris(carboxymethyl)-10-(2′-hydroxypropyl)-1,4,7,10-tetraazacyclododecane.

3. The composition of claim 1 wherein the mole ratio of said complex salt excipient to said contrast agent is between about 0.05 and 10 percent.

4. The composition of claim 1 wherein said metal ion is selected from paramagnetic metal atoms, lanthanide series elements, yttrium, and the transition series elements.

5. The composition of claim 4 wherein said paramagnetic metals are selected from gadolinium(III), dysprosium(III), manganese(II), manganese(III), chromium(III), iron(II) and iron(III).

6. The composition of claim 1 wherein said metal ion M complexed with an organic ligand is gadolinium(III) 1,4,7-tris(carboxymethyl)-10-(2′-hydroxypropyl)-1,4,7,10-tetraazacyclododecane and said excipient is calcium bis[1,4,7-tris(carboxy-methyl)-10-(2′-hydroxypropyl)-1,4,7,10-tetraazacyclododecanatocalcium(II)].

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2010
From: BRACCO INTERNATIONAL B.V.
To: BRACCO SUISSE SA
Reel/Frame 024990/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2007
From: CHANG, C. ALLEN; KUMAR, KRISHAN; TWEEDLE, MICHAEL F.
To: E.R. SQUIBB & SONS, INC.
Reel/Frame 019543/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2007
From: E.R. SQUIBB & SONS, INC.
To: BRACCO INTERNATIONAL BV
Reel/Frame 019543/0252 →